These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 25212409

  • 1. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
    Yehuda R, Bierer LM, Pratchett LC, Lehrner A, Koch EC, Van Manen JA, Flory JD, Makotkine I, Hildebrandt T.
    Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of Prolonged Exposure for PTSD in U.S. combat veterans.
    Lehrner A, Hildebrandt T, Bierer LM, Flory JD, Bader HN, Makotkine I, Yehuda R.
    Behav Res Ther; 2021 Sep; 144():103924. PubMed ID: 34298438
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of national implementation of prolonged exposure therapy in Veterans Affairs care.
    Eftekhari A, Ruzek JI, Crowley JJ, Rosen CS, Greenbaum MA, Karlin BE.
    JAMA Psychiatry; 2013 Sep; 70(9):949-55. PubMed ID: 23863892
    [Abstract] [Full Text] [Related]

  • 4. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial.
    van den Berg DP, de Bont PA, van der Vleugel BM, de Roos C, de Jongh A, Van Minnen A, van der Gaag M.
    JAMA Psychiatry; 2015 Mar; 72(3):259-67. PubMed ID: 25607833
    [Abstract] [Full Text] [Related]

  • 5. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.
    Flanagan JC, Sippel LM, Wahlquist A, Moran-Santa Maria MM, Back SE.
    J Psychiatr Res; 2018 Mar; 98():64-69. PubMed ID: 29294429
    [Abstract] [Full Text] [Related]

  • 6. Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome.
    Wangelin BC, Powers MB, Smits JA, Tuerk PW.
    Contemp Clin Trials; 2013 Nov; 36(2):319-26. PubMed ID: 23939512
    [Abstract] [Full Text] [Related]

  • 7. Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial.
    Zoellner LA, Telch M, Foa EB, Farach FJ, McLean CP, Gallop R, Bluett EJ, Cobb A, Gonzalez-Lima F.
    J Clin Psychiatry; 2017 Jul; 78(7):e782-e789. PubMed ID: 28686823
    [Abstract] [Full Text] [Related]

  • 8. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial.
    Rauch SA, King AP, Abelson J, Tuerk PW, Smith E, Rothbaum BO, Clifton E, Defever A, Liberzon I.
    Depress Anxiety; 2015 Mar; 32(3):204-12. PubMed ID: 25639570
    [Abstract] [Full Text] [Related]

  • 9. Combining group-based exposure therapy with prolonged exposure to treat U.S. Vietnam veterans with PTSD: a case study.
    Ready DJ, Vega EM, Worley V, Bradley B.
    J Trauma Stress; 2012 Oct; 25(5):574-7. PubMed ID: 22965936
    [Abstract] [Full Text] [Related]

  • 10. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R, Yehuda R, Golier J, McEwen B, Harvey P, Maria NS.
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl.
    Tuerk PW, Wangelin BC, Powers MB, Smits JAJ, Acierno R, Myers US, Orr SP, Foa EB, Hamner MB.
    Cogn Behav Ther; 2018 Sep; 47(5):351-371. PubMed ID: 29448886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT.
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [Abstract] [Full Text] [Related]

  • 17. Randomized Controlled Trial of Home-Based Telehealth Versus In-Person Prolonged Exposure for Combat-Related PTSD in Veterans: Preliminary Results.
    Yuen EK, Gros DF, Price M, Zeigler S, Tuerk PW, Foa EB, Acierno R.
    J Clin Psychol; 2015 Jun; 71(6):500-12. PubMed ID: 25809565
    [Abstract] [Full Text] [Related]

  • 18. Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials.
    Steenkamp MM, Litz BT, Hoge CW, Marmar CR.
    JAMA; 2015 Aug 04; 314(5):489-500. PubMed ID: 26241600
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
    Lindley SE, Carlson EB, Hill K.
    J Clin Psychopharmacol; 2007 Dec 04; 27(6):677-81. PubMed ID: 18004136
    [Abstract] [Full Text] [Related]

  • 20. A meta-analytic review of prolonged exposure for posttraumatic stress disorder.
    Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, Foa EB.
    Clin Psychol Rev; 2010 Aug 04; 30(6):635-41. PubMed ID: 20546985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.